{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:45:40Z","timestamp":1790891140521,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.metabol.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T13:18:52Z","timestamp":1488979132000},"page":"52-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome"],"prefix":"10.1016","volume":"71","author":[{"given":"Alice Y.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni Z.","family":"Lalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumpa","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickey E.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder J.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Sreekumaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2017.03.002_bb0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.fertnstert.2006.03.012","article-title":"Diagnosis, phenotype, and prevalence of polycystic ovary syndrome","volume":"86","author":"Carmina","year":"2006","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.metabol.2017.03.002_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2017.03.002_bb0020","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"et al; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.metabol.2017.03.002_bb0040","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.metabol.2017.03.002_bb0045","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","article-title":"Capturing heterogeneity in gene expression studies by surrogate variable analysis","volume":"3","author":"Leek","year":"2007","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2006-1665","article-title":"Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome","volume":"92","author":"Corton","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2017.03.002_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/dem380","article-title":"Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry","volume":"23","author":"Corton","year":"2008","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.metabol.2017.03.002_bb0060","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2010-0220","article-title":"Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation","volume":"95","author":"Insenser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.metabol.2017.03.002_bb0065","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1039\/C6MB00420B","article-title":"Serum metabolomics of Indian women with polycystic ovary syndrome using (1)H NMR coupled with a pattern recognition approach","volume":"12","author":"RoyChoudhury","year":"2016","journal-title":"Mol Biosyst"},{"issue":"11","key":"10.1016\/j.metabol.2017.03.002_bb0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/molehr\/gas029","article-title":"Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study","volume":"18","author":"Atiomo","year":"2012","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"10.1016\/j.metabol.2017.03.002_bb0075","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC\u2013MS","volume":"58","author":"Escobar-Morreale","year":"2012","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.metabol.2017.03.002_bb0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11306-014-0726-y","article-title":"Lipidomic analysis of plasma samples from women with polycystic ovary syndrome","volume":"11","author":"Haoula","year":"2015","journal-title":"Metabolomics"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/2213235X01666131203230512","article-title":"Metabolic evidence of diminished lipid oxidation in women with polycystic ovary syndrome","volume":"2","author":"Whigham","year":"2014","journal-title":"Curr Metabolomics"},{"key":"10.1016\/j.metabol.2017.03.002_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/pr401130w","article-title":"Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry","volume":"13","author":"Zhao","year":"2014","journal-title":"J Proteome Res"},{"issue":"5","key":"10.1016\/j.metabol.2017.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/db11-0874","article-title":"Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes","volume":"61","author":"Dutta","year":"2012","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.metabol.2017.03.002_bb0105","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","article-title":"Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach","volume":"407","author":"Dong","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.metabol.2017.03.002_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","article-title":"Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS","volume":"448","author":"Wang","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.metabol.2017.03.002_bb0115","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.amjcard.2004.02.058","article-title":"The Dallas heart study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health","volume":"93","author":"Victor","year":"2004","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3132\/dvdr.2008.016","article-title":"Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas heart study","volume":"5","author":"Chen","year":"2008","journal-title":"Diab Vasc Dis Res"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0169-2607(86)90106-9","article-title":"MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test","volume":"23","author":"Pacini","year":"1986","journal-title":"Comput Methods Programs Biomed"},{"issue":"7","key":"10.1016\/j.metabol.2017.03.002_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI118083","article-title":"Relationships of generalized and regional adiposity to insulin sensitivity in men","volume":"96","author":"Abate","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.metabol.2017.03.002_bb0145","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2015-2640","article-title":"Impact of long-term poor and good glycemic control on metabolomics alterations in type 1 diabetic people","volume":"101","author":"Dutta","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2017.03.002_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1373\/clinchem.2010.157115","article-title":"Increasing liquid chromatography\u2013tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3","volume":"57","author":"Netzel","year":"2011","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.metabol.2017.03.002_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bioinformatics\/btg382","article-title":"A global test for groups of genes: testing association with a clinical outcome","volume":"20","author":"Goeman","year":"2004","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.metabol.2017.03.002_bb0165","doi-asserted-by":"crossref","first-page":"e116221","DOI":"10.1371\/journal.pone.0116221","article-title":"Metabolomics data normalization with EigenMS","volume":"9","author":"Karpievitch","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.metabol.2017.03.002_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","article-title":"Metabolomics in polycystic ovary syndrome","volume":"429","author":"Murri","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.metabol.2017.03.002_bb0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.metabol.2017.03.002_bb0185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.metabol.2013.01.007","article-title":"Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness","volume":"62","author":"Batch","year":"2013","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2017.03.002_bb0190","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00125-009-1637-8","article-title":"Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men","volume":"53","author":"Tai","year":"2010","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2017.03.002_bb0205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2337\/diabetes.51.3.599","article-title":"Mechanism of amino acid-induced skeletal muscle insulin resistance in humans","volume":"51","author":"Krebs","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.metabol.2017.03.002_bb0210","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/db07-0123","article-title":"Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms","volume":"56","author":"Zhang","year":"2007","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2017.03.002_bb0215","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.metabol.2008.09.001","article-title":"Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose","volume":"57","author":"Kalogeropoulou","year":"2008","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.metabol.2017.03.002_bb0220","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1172\/JCI64801","article-title":"2-Aminoadipic acid is a biomarker for diabetes risk","volume":"123","author":"Wang","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2017.03.002_bb0225","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.metabol.2015.01.008","article-title":"Effect of insulin sensitizer therapy on amino acids and their metabolites","volume":"64","author":"Irving","year":"2015","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2017.03.002_bb0230","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/pr200815c","article-title":"Amine metabolomics of hyperglycemic endothelial cells using capillary LC\u2013MS with isobaric tagging","volume":"10","author":"Yuan","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2017.03.002_bb0235","series-title":"Dietary reference intakes for calcium and vitamin D","year":"2010"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1530\/EC-15-0001","article-title":"Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study","volume":"4","author":"Garg","year":"2015","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.metabol.2017.03.002_bb0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-13-0617","article-title":"The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review","volume":"169","author":"Krul-Poel","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.metabol.2017.03.002_bb0250","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/diacare.28.5.1228","article-title":"Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.metabol.2017.03.002_bb0255","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjcard.2010.05.027","article-title":"et al; Intermountain Heart Collaborative (IHC) study group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population","volume":"106","author":"Anderson","year":"2010","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.metabol.2017.03.002_bb0260","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-09-0432","article-title":"Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome","volume":"161","author":"Wehr","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.metabol.2017.03.002_bb0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5653\/cerm.2014.41.2.80","article-title":"2Vitamin D deficiency in women with polycystic ovary syndrome","volume":"41","author":"Kim","year":"2014","journal-title":"Clin Exp Reprod Med"},{"issue":"17\u201318","key":"10.1016\/j.metabol.2017.03.002_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00508-015-0768-9","article-title":"Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities","volume":"128","author":"Figurova","year":"2016","journal-title":"Wien Klin Wochenschr"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517300823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517300823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:13:35Z","timestamp":1758428015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517300823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":53,"alternative-id":["S0026049517300823"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.03.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}